Zynerba Pharmaceuticals to Host Clinical Research Day on December 15, 2016 to Discuss the Role of ZYN002 CBD Gel in Multiple Diseases
/
Date08 Dec 2016
Speakers include world-renowned physicians Meeting to begin at 8:00 am ET; webcast will be available DEVON, Pa., Dec. 08, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals,... Read More →
Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis
/
Date08 Dec 2016
Topline results from CIMPASI-1, the second of three Phase 3 trials in psoriasis clinical development program Findings confirm CIMZIA results observed in earlier CIMPASI-2 trial... Read More →
Global Diagnostic Imaging Market will reach USD 33.50 Billion by 2021: Zion Market Research
/
Date08 Dec 2016
Sarasota, FL, Dec. 08, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Diagnostic Imaging Market by Products (X-ray Imaging Systems, CT... Read More →
European Hospital Leverages OmniComm Systems’ TrialMaster® EDC To Integrate Electronic Health Records
/
Date07 Dec 2016
FORT LAUDERDALE, Fla., Dec. 07, 2016 (GLOBE NEWSWIRE) — A large nationwide infectious disease observational study in Europe will receive electronic data capture (EDC) technology... Read More →
XBiotech Completes Enrollment in Global Phase III Study using Xilonix Monotherapy to Treat Advanced Colorectal Cancer
/
Date07 Dec 2016
AUSTIN, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that enrollment has been completed in... Read More →
Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management
/
Date07 Dec 2016
New iPro(TM)2 myLog App Collects Data from Continuous Glucose Monitors (CGM) and Fitbit Activity Trackers, Provides Meaningful Insights on How Exercise Impacts Glucose Levels... Read More →
Ocera Completes Enrollment of STOP-HE, a Phase 2b Study of OCR-002 in Hospitalized Patients with Hepatic Encephalopathy
/
Date07 Dec 2016
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2016 (GLOBE NEWSWIRE) — Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced it has completed enrollment in... Read More →
SteadyMed Hires Pulmonary Hypertension Veteran to Lead Patient Advocacy and Community Relations
/
Date07 Dec 2016
SAN RAMON, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) — SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a specialty pharmaceutical company focused on the development of drug product candidates... Read More →
Neos Therapeutics to Present at BMO Prescription for Success Healthcare Conference
/
Date07 Dec 2016
DALLAS/FORT WORTH, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products... Read More →
Origent Data Sciences and Cytokinetics Present Analyses Demonstrating Baseline Data Predict Measures of Vital Capacity in Patients With ALS
/
Date07 Dec 2016
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) — Origent Data Sciences, Inc. (Origent) and Cytokinetics, Inc. (Nasdaq:CYTK) today announced results from the first... Read More →